chronic kidney disease

News

NHS trust rolls out digital health tool for kidney disease

An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.

News

Bayer trial combines two top drugs for kidney disease

Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.

News

AZ partners with Aptar on kidney disease-detecting AI

AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD).

News

When licensing deals go bad - Novo sues KBP Bio for $830m

Novo Nordisk lawsuit claims KBP concealed clinical data ahead of a $1.3bn licensing deal for blood pressure drug candidate ocedurenone.

News

Ozempic is first GLP-1 drug FDA-approved for kidney disease

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics.

News

Unicycive eyes June FDA verdict for hyperphosphataemia drug

The FDA has started a review of Unicycive Therapeutics' drug for hyperphosphataemia in patients with chronic kidney disease (CKD) who need dialysis, which hopes to improve on 'onerous' phos

NHS trust rolls out digital health tool for kidney disease

Bayer trial combines two top drugs for kidney disease

AZ partners with Aptar on kidney disease-detecting AI

When licensing deals go bad - Novo sues KBP Bio for $830m

Ozempic is first GLP-1 drug FDA-approved for kidney disease

Unicycive eyes June FDA verdict for hyperphosphataemia drug

New UK PM shuts down science and tech department

Discover a new era of healthcare panel engagement: Grounded ...

chronic kidney disease

Editor's Picks